AXL and acute myeloid leukemia: ALKBH5, in turn, affects the mRNA stability of receptor tyrosine kinase AXL through an m6A‐dependent mechanism, promoting LSC self‐renewal and AML progression, while ALKBH5 has no impact on normal hematopoiesis.258